HCPCS Level II
J9353
Injection, margetuximab-cmkb, 5 mg
Codes near J9353
These sit next to J9353 in the CMS Level II file. All J codes
- J9348Injection, naxitamab-gqgk, 1 mg
- J9349Injection, tafasitamab-cxix, 2 mg
- J9350Injection, mosunetuzumab-axgb, 1 mg
- J9351Injection, topotecan, 0.1 mg
- J9352Injection, trabectedin, 0.1 mg
- J9354Injection, ado-trastuzumab emtansine, 1 mg
- J9355Injection, trastuzumab, excludes biosimilar, 10 mg
- J9356Injection, trastuzumab, 10 mg and hyaluronidase-oysk
- J9357Injection, valrubicin, intravesical, 200 mg
- J9358Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 74527-0022-02 | Margenza | MacroGenics, Inc | 50 |
| 74527-0022-03 | Margenza | MacroGenics, Inc | 200 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.